Substantive final action
HB3057
Read 3rd time RV#2043
Relating to health benefit plan coverage for chimeric antigen receptor T-cell therapy.
Passed House May 10, 2025⭐ Substantive final action
Yea (109)
Nay (22)
Not Voting (3)
Absent (16)
Republicans (88)
73% yea among members casting a yea or nay vote (61–22).
Democrats (62)
100% yea among members casting a yea or nay vote (48–0).